Sutro Biopharma (STRO) EBT Margin (2017 - 2025)
Sutro Biopharma (STRO) reported EBT Margin of 709.76% for Q4 2025, down 23648.0% on a YoY basis from N/an in Q4 2024, and down 21.0% sequentially from 586.58% in Q3 2025.
Sutro Biopharma (STRO) EBT Margin (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of EBT Margin data on file, last reported at 709.76% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin fell 23648.0% year-over-year to 709.76%; the trailing twelve-month figure through Dec 2025 stood at 187.65% (up 17516.0% YoY), and the FY2025 full-year result was 186.55%, up 17626.0% from the prior year.
- EBT Margin eased to 709.76% in Q4 2025, from 586.58% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 41.22% in Q4 2023 to a low of 709.76% in Q4 2025.
- A 5-year average of 324.23% and a median of 365.69% in 2021 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin plunged 52904 bps in 2022 and surged 44198 bps in 2023, its largest moves.
- Tracing STRO's EBT Margin over 5 years: stood at 357.85% in 2021, then fell by 12 bps to 400.76% in 2022, then jumped by 110 bps to 41.22% in 2023, then plunged by 1248 bps to 473.28% in 2024, then plunged by 50 bps to 709.76% in 2025.
- Business Quant data shows STRO's EBT Margin at 709.76% in Q4 2025, 586.58% in Q3 2025, and 18.07% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -709.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -709.76% |
| Sep 30, 2025 | -586.58% |
| Jun 30, 2025 | -18.07% |
| Mar 31, 2025 | -388.67% |
| Dec 31, 2024 | -473.28% |
| Sep 30, 2024 | -572.62% |
| Jun 30, 2024 | -186.77% |
| Mar 31, 2024 | -447.52% |
| Dec 31, 2023 | 41.22% |
| Sep 30, 2023 | -280.34% |
| Jun 30, 2023 | -368.55% |
| Mar 31, 2023 | -391.79% |
| Dec 31, 2022 | -400.76% |
| Sep 30, 2022 | -77.50% |
| Jun 30, 2022 | -83.68% |
| Mar 31, 2022 | -663.22% |
| Dec 31, 2021 | -357.85% |
| Sep 30, 2021 | -362.83% |
| Jun 30, 2021 | -21.93% |
| Mar 31, 2021 | -134.17% |